| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/00126334-199910010-00001 |
| P698 | PubMed publication ID | 10843523 |
| P50 | author | Anne-Mieke Vandamme | Q28743834 |
| P2093 | author name string | J Desmyter | |
| E De Clercq | |||
| P Hermans | |||
| L Stuyver | |||
| M Van Ranst | |||
| T Harrer | |||
| M Witvrouw | |||
| R Schuurman | |||
| A M Vandamme | |||
| J C Schmit | |||
| E. De Clercq | |||
| E Van Wijngaerden | |||
| K Van Laethem | |||
| K Van Vaerenbergh | |||
| S Sprecher | |||
| E. Van Wijngaerden | |||
| J. Desmyter | |||
| J.-C. Schmit | |||
| K. Van Laethem | |||
| K. Van Vaerenbergh | |||
| L. Stuyver | |||
| P. Hermans | |||
| M. Van Ranst | |||
| M. Witvrouw | |||
| T. Harrer | |||
| R. Schuurman | |||
| S. Sprecher | |||
| V De Vroey | |||
| V. De Vroey | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 107 | |
| 107-18 | |||
| P577 | publication date | 1999-10-01 | |
| P1433 | published in | Journal of Acquired Immune Deficiency Syndromes | Q6294722 |
| P1476 | title | Phenotypic assays and sequencing are less sensitive than point mutation assays for detection of resistance in mixed HIV-1 genotypic populations | |
| Phenotypic Assays and Sequencing Are Less Sensitive Than Point Mutation Assays for Detection of Resistance in Mixed HIV-1 Genotypic Populations | |||
| P478 | volume | 22 |
| Q35742512 | A Guide to HIV-1 Reverse Transcriptase and Protease Sequencing for Drug Resistance Studies |
| Q35647691 | Accurate sampling and deep sequencing of the HIV-1 protease gene using a Primer ID |
| Q34737411 | Analysis of low-frequency mutations associated with drug resistance to raltegravir before antiretroviral treatment |
| Q33938373 | Biomarker discovery using targeted maximum-likelihood estimation: application to the treatment of antiretroviral-resistant HIV infection |
| Q36255602 | Characterization of the Drug Resistance Profiles of Patients Infected with CRF07_BC Using Phenotypic Assay and Ultra-Deep Pyrosequencing |
| Q34567556 | Characterizing the emergence and persistence of drug resistant mutations in HIV-1 subtype C infections using 454 ultra deep pyrosequencing |
| Q34041782 | Comparison between sequence analysis and a line probe assay for testing genotypic resistance of human immunodeficiency virus type 1 to antiretroviral drugs. |
| Q41284477 | Comparison of clinical performances among Roche Cobas HPV, RFMP HPV PapilloTyper and Hybrid Capture 2 assays for detection of high-risk types of human papillomavirus. |
| Q37156918 | Comparison of oligonucleotide ligation assay and consensus sequencing for detection of drug-resistant mutants of human immunodeficiency virus type 1 in peripheral blood mononuclear cells and plasma |
| Q28544988 | Deep sequencing of HIV-1 near full-length proviral genomes identifies high rates of BF1 recombinants including two novel circulating recombinant forms (CRF) 70_BF1 and a disseminating 71_BF1 among blood donors in Pernambuco, Brazil |
| Q40291316 | Differential maintenance of the M184V substitution in the reverse transcriptase of human immunodeficiency virus type 1 by various nucleoside antiretroviral agents in tissue culture |
| Q39746816 | Discordance between genotypic and phenotypic drug resistance profiles in human immunodeficiency virus type 1 strains isolated from peripheral blood mononuclear cells |
| Q34352000 | Discordances between interpretation algorithms for genotypic resistance to protease and reverse transcriptase inhibitors of human immunodeficiency virus are subtype dependent |
| Q46134248 | Dual-priming oligonucleotide-based multiplex PCR for the detection of Helicobacter pylori and determination of clarithromycin resistance with gastric biopsy specimens |
| Q30870822 | Enhanced detection of viral diversity using partial and near full-length genomes of human immunodeficiency virus Type 1 provirus deep sequencing data from recently infected donors at four blood centers in Brazil |
| Q41115175 | Evidence for deleterious hepatitis C virus quasispecies mutation loads that differentiate the response patterns in IFN-based antiviral therapy |
| Q42910007 | Evolution of primary and compensatory lamivudine resistance mutations in chronic hepatitis B virus-infected patients during long-term lamivudine treatment, assessed by a line probe assay. |
| Q36098805 | Feasibility of detecting human immunodeficiency virus type 1 drug resistance in DNA extracted from whole blood or dried blood spots |
| Q33583299 | Frequency of Drug-Resistant Variants of HIV-1 Coexistent With Wild-Type in Treatment-Naive Patients of India |
| Q56965171 | Frequency of drug-resistant variants of HIV-1 coexistent with wild-type in treatment-naive patients of India |
| Q33906239 | Genotypic testing for human immunodeficiency virus type 1 drug resistance |
| Q41929325 | High prevalence of HIV-1 transmitted drug-resistance mutations from proviral DNA massively parallel sequencing data of therapy-naïve chronically infected Brazilian blood donors |
| Q33784107 | High-resolution quantification of hepatitis C virus genome-wide mutation load and its correlation with the outcome of peginterferon-alpha2a and ribavirin combination therapy |
| Q54469450 | Merkel cell polyomavirus DNA detection in lesional and nonlesional skin from patients with Merkel cell carcinoma or other skin diseases. |
| Q34200074 | Monitoring drug resistance in chronic hepatitis B virus (HBV)-infected patients during lamivudine therapy: evaluation of performance of INNO-LiPA HBV DR assay |
| Q38703935 | Multimethod Longitudinal HIV Drug Resistance Analysis in Antiretroviral-Therapy-Naive Patients |
| Q39748924 | Multiple viral genetic analyses detect low-level human immunodeficiency virus type 1 replication during effective highly active antiretroviral therapy |
| Q34252835 | Mutagenically separated PCR assay for rapid detection of M41L and K70R zidovudine resistance mutations in CRF01_AE (subtype E) human immunodeficiency virus type 1. |
| Q37058422 | Novel Enzyme-Linked Minisequence Assay for Genotypic Analysis of Human Immunodeficiency Virus Type 1 Drug Resistance |
| Q37488838 | Performance evaluation of the HepB Typer-Entecavir kit for detection of entecavir resistance mutations in chronic hepatitis B. |
| Q28344476 | Prevalence and characteristics of multinucleoside-resistant human immunodeficiency virus type 1 among European patients receiving combinations of nucleoside analogues |
| Q28478459 | Prevalence and impact of minority variant drug resistance mutations in primary HIV-1 infection |
| Q45257444 | Prevalence of genotypic resistance to nucleoside analogues and protease inhibitors in antiretroviral-naive HIV patients in Campania, Italy |
| Q34454630 | Rapid and sensitive oligonucleotide ligation assay for detection of mutations in human immunodeficiency virus type 1 associated with high-level resistance to protease inhibitors |
| Q33974339 | Rapid identification of Mycobacteria to the species level using INNO-LiPA Mycobacteria, a reverse hybridization assay |
| Q40909665 | Sequencing-based detection of low-frequency human immunodeficiency virus type 1 drug-resistant mutants by an RNA/DNA heteroduplex generator-tracking assay |
| Q37018369 | The Genetic Basis of HIV-1 Resistance to Reverse Transcriptase and Protease Inhibitors. |
| Q42314454 | The HIV-1 transmission bottleneck |
| Q42219806 | Theoretical and experimental assessment of degenerate primer tagging in ultra-deep applications of next-generation sequencing |
| Q44470116 | Trofile HIV co-receptor usage assay. |
| Q35574598 | Update on HIV resistance and resistance testing |
| Q35455456 | Use of amplification refractory mutation system PCR assay as a simple and effective tool to detect HIV-1 drug resistance mutations |
Search more.